I am a
Home I AM A Search Login

Papers of the Week


Papers: 11 Jan 2020 - 17 Jan 2020


Human Studies, Pharmacology/Drug Development

PAIN TYPE:
Migraine/Headache


2020 05 19


Neurology


94


20

Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy.

Authors

Mullin K, Kudrow D, Croop R, Lovegren M, Conway CM, Coric V, Lipton RB
Neurology. 2020 05 19; 94(20):e2121-e2125.
PMID: 31932515.

Abstract

To provide the first clinical report that 2 calcitonin gene-related peptide (CGRP) therapies, a small molecule CGRP receptor antagonist and an anti-CGRP receptor antibody, can be used concomitantly to treat refractory migraine.